Column: That blockbuster Alzheimer"s drug? It"s not a cure
Biogen Inc. and Eisai Co. caused a stir in September when they announced positive results in a late-stage trial for a closely watched Alzheimer"s drug, lecanemab. Doctors tempered…
Biogen Inc. and Eisai Co. caused a stir in September when they announced positive results in a late-stage trial for a closely watched Alzheimer"s drug, lecanemab. Doctors tempered…